trump and tirzepatide Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices President Trump unveils deal to
Description
GLP-1 drugs have become powerful tools for weight loss.A new review looked at what happens a year or more after people stop taking them.
Find out more about the shifts in purchasing habits.
Blood pressure also showed reductions during follow-up
Ozempic is a GLP-1 agonist drug intended to treat diabetes
And the clinical results have been impressive
Conclusion: Oral semaglutides clinical improvement over Januvia (sitagliptin, Merck) is 17 percent a historically high level of innovation
